Astrocyte Pharmaceuticals Inc. — Form D
Astrocyte Pharmaceuticals Inc. of GROTON, CT, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-28. The offering totals $5.0M, of which $2.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-10-28
- Form: D
- Accession: 0001703017-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.8M
- Remaining: $2.2M
- Investors: 48
- Date of first sale: 2022-10-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-463124
Issuer
- Name: Astrocyte Pharmaceuticals Inc.
- CIK: 0001703017
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 93 SHENNECOSSETT ROAD, GROTON, CT, 06340
- Phone: 617-444-8765
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jeffrey S Arnold | Director | Groton, CT |
| Christine S Gallagher | Director | Groton, CT |
| Jeffrey S Ives | Director | Groton, CT |
| William S Korinek | Director | Groton, CT |
| Jackson S Streeter | Director | Groton, CT |
| William S Korinek | Executive Officer | Groton, CT |
| Jeffrey Arnold | Director | Newton, MA |
| Jeffrey L Ives | Director | Newton Centre, MA |
| Jeffrey Ives | Director | Groton, CT |
| William Korinek | Director | Groton, CT |
| William Korinek | Executive Officer | Groton, CT |
| James D Lechleiter | Director | Cambridge, MA |
Other filings by this issuer (3)
More